Prolonged disease-free survival in patients with acute myeloid leukemia in first relapse treated with gemtuzumab ozogamicin (Mylotarg (TM), CMA-676) followed by hematopoietic stem cell transplantation.


Conference Paper

Full Text

Duke Authors

Cited Authors

  • Sievers, EL; Larson, RA; Estey, E; Lowenberg, B; Erba, HP; Gramatzki, M; List, A; Sierra, J; Stadtmauer, EA; Tarantolo, S; Berger, MS; Leopold, LH; Eten, C; Munteanu, M; Stone, A; Bernstein, ID; Appelbaum, FR

Published Date

  • November 16, 2000

Published In

Volume / Issue

  • 96 / 11

Start / End Page

  • 320A - 320A

Published By


  • 1

International Standard Serial Number (ISSN)

  • 0006-4971